Internal Medicine, Hematology & Oncology · Orlando, FL
NPI
1841506854
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
22 W Underwood St
Orlando, FL, 32806
Phone (407) 648-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
381 services
Medicare patients, 2024
208
Average age 74
Drug cost, 2024
$3.7M
1,456 prescriptions
Company payments, 2025
$7,807
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ana E Cuesta Fernandez was code 99213 (office e&m - established), 89 times for 73 patients. In total Ana E Cuesta Fernandez billed 381 services in 12 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 89 | 73 | $43.40 | $3,863 |
| 99214 Office E&M - Established | Facility | 57 | 35 | $73.12 | $4,168 |
| 99213 Office E&M - Established | Office | 45 | 37 | $61.68 | $2,776 |
| 99223 Hospital E&M - Initial | Facility | 44 | 44 | $135.09 | $5,944 |
| 99215 Office E&M - Established | Facility | 34 | 27 | $102.37 | $3,480 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 19 | $92.58 | $2,777 |
| 99215 Office E&M - Established | Office | 24 | 15 | $122.46 | $2,939 |
| 99214 Office E&M - Established | Office | 22 | 14 | $83.18 | $1,830 |
By year: 2022 $31K for 431 services; 2023 $35K for 456 services; 2024 $31K for 381 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ana E Cuesta Fernandez prescribed most often to Medicare patients was Anastrozole, with 630 prescriptions and refills. In total Ana E Cuesta Fernandez wrote 1,456 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 630 | 1,805 | 220 | $12K |
| Letrozole Generic | 177 | 478 | 67 | $4,490 |
| Ibrance Palbociclib | 149 | 149 | 20 | $2.2M |
| Kisqali Ribociclib Succinate | 64 | 66 | Under 11 | $940K |
| Exemestane Generic | 57 | 126 | 16 | $11K |
| Prochlorperazine Maleate Generic | 46 | 46 | 36 | $535 |
| Alendronate Sodium Generic | 37 | 104 | Under 11 | $262 |
| Ondansetron Hcl Generic | 34 | 34 | 25 | $658 |
| Gabapentin Generic | 25 | 29 | Under 11 | $253 |
| Eliquis Apixaban | 24 | 44 | Under 11 | $25K |
| Prednisone Generic | 20 | 20 | Under 11 | $36.84 |
| Tamoxifen Citrate Generic | 17 | 45 | Under 11 | $610 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 17 | 17 | 11 | $221 |
| Temazepam Generic | 11 | 13 | Under 11 | $212 |
| Olanzapine Generic | 11 | 15 | Under 11 | $80.29 |
Brand drugs: 288 claims; generic drugs: 1,168 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ana E Cuesta Fernandez $7,807 ($7,807 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $4,149.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.